Live feed16:05:09·1hINSIDERFilingvia QuantisnowChief Executive Officer Ceesay Abraham sold $86,565 worth of shares (2,210 units at $39.17) as part of a pre-agreed trading plan, decreasing direct ownership by 0.48% to 456,767 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
